Ishita Drugs & Industries Ltd. Press Release Apr 10 2026
Filed with BSE · · 2 pages · English
Summary by 6ix AI
It states that no certificates have been mutilated or cancelled, and there has been no substitution of names in the register of members. The document is addressed to the Department of Corporate Services at BSE Limited and requests acknowledgment of the information provided.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Ishita Drugs & Industries Ltd. on 6ix
Earlier from Ishita Drugs & Industries
- Ishita Drugs & Industries Ltd. Press Release Mar 26 2026
- Ishita Drugs & Industries Ltd. Press Release Feb 24 2026
- Ishita Drugs & Industries Ltd. Press Release Jan 30 2026
- Ishita Drugs & Industries Ltd. Press Release Jan 08 2026
- Ishita Drugs & Industries Ltd. Press Release Jan 02 2026
Later from Ishita Drugs & Industries
- Ishita Drugs & Industries Ltd. Press Release Apr 13 2026
- Ishita Drugs & Industries Ltd. Press Release Apr 22 2026
- Ishita Drugs & Industries Ltd. Press Release Apr 28 2026
- Ishita Drugs & Industries Ltd. Press Release May 23 2026
- Ishita Drugs & Industries Ltd. Press Release May 30 2026
Follow Ishita Drugs & Industries into a list and get an email when it puts out news.
Follow Ishita Drugs & Industries